A new competition to address health complications that arise as a result of diabetes has been announced by Enterprise Ireland and the HSE through the Small Business Innovation Research (SBIR) initiative.
The health and wellness challenges aim to harness innovation and technology to help diabetes patients avoid the development of typical complications associated with the disease and to receive appropriate care at an earlier stage when complications arise.
This is the first SBIR collaboration between Enterprise Ireland and the HSE which offers a unique opportunity for innovative companies to co-design solutions with clinicians. Through this SBIR challenge, successful companies are awarded a 100% funded development contract with the HSE, with up to €200K available to multiple winners across a two-phase competitive process.
Phase 1 is an initial feasibility study, followed by product development in Phase 2, where companies retain the IP developed.
The diabetes challenges will specifically target two areas - reducing the risk of women developing Type 2 diabetes following gestational diabetes and screening for diabetic foot disease in all patients with diabetes.
Gestational diabetes affects one in six pregnancies globally and these women are at increased risk of developing diabetes after the pregnancy. All people with diabetes are at increased risk of developing complications which can cause damage to the feet such as ulceration and amputation.
The Invitation to Tender will be released on e-tenders on the week beginning Monday 17th December. Interested parties will need to be registered on e-tenders to access and apply.
Speaking this week, The HSE’s Chief Clinical Information Officer, Yvonne Goff said, "We are delighted to partner with Enterprise Ireland on this Small Business Innovative Research Programme. Technology is a fundamental enabler in the effective and efficient delivery of health services. This initiative represents a significant combined effort to harness the potential of technology to deliver real solutions for diabetes patients."
Head of Innovation at Enterprise Ireland, Tom Kelly added, "Diabetes has become a serious global health issue which can benefit from innovative solutions to help reduce complications from the disease. Enterprise Ireland is proud to partner with the HSE on our first SBIR health challenge to harness the best in innovation to address a global health problem."